Xilio Development
Price & Volume
Stats
See more52W Range | $6.46-$12.58 |
Market Cap | $59.2M |
Shares Short | 412,963 |
Financials
See moreRevenue (12 Mos) | $64M |
Revenue Growth (YoY) | 131.2% |
Gross Profit (12 Mos) | $53.2M |
Diluted EPS | -$0.60 |
News
See moreYahoo Finance • 3 months ago
Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer
Yahoo Finance • 5 months ago
Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
Yahoo Finance • 5 months ago
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 6 months ago
Most and least shorted small-to-mid-cap stocks
About
CEO | Dr. Rene Russo BCPS, Pharm.D. |
CFO | Mr. Christopher Frankenfield |
Address | 828 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 76 |